Abstract
Beta-secretase 1 (BACE1) gene encodes a transmembrane protease from the peptidase A1 family of aspartic proteases whose role in the pathogenesis of Alzheimer’s disease has been assessed. The enzymatic activity of BACE1 on several proteins implicated in epileptogenesis implies its role in the pathogenesis of epilepsy. In the present study, we assessed expression of BACE1 and its naturally occurring antisense (BACE1-AS) in peripheral blood of 40 epileptic patients and 40 age- and sex-matched healthy subjects. We did not detect either any difference in the expression of these genes between cases and controls or significant correlation between their expressions and participants’ age. However, we demonstrated a significant correlation between expression levels of BACE1 and BACE1-AS which supports the previously suggested feed-forward mechanism of regulation between these two transcripts. Future studies in larger sample sizes are needed to elaborate the function of BACE1 in epilepsy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alfradique I, Vasconcelos MM (2007) Juvenile myoclonic epilepsy. Arq Neuropsiquiatr 65:1266–1271
Chen Q, Liu X, Xu L, Wang Y, Wang S, Li Q, Huang Y, Liu T (2016) Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion. Oncol Rep 35:1916–1924
Decourt B, Sabbagh MN (2011) BACE1 as a potential biomarker for Alzheimer’s disease. J Alzheimers Dis 24:53–59
Engström PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, Brozzi A, Luzi L, Tan SL, Yang L (2006) Complex loci in human and mouse genomes. PLoS Genet 2:e47
Fabene PF, Mora GN, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14:1377–1383
Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, Laurent GS III, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase. Nat Med 14:723–730
Greco S, Zaccagnini G, Fuschi P, Voellenkle C, Carrara M, Sadeghi I, Bearzi C, Maimone B, Castelvecchio S, Stellos K (2017) Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure. Cardiovasc Res 113:453–463
Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325
Hitt BD, Jaramillo TC, Chetkovich DM, Vassar R (2010) BACE1−/−mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol Neurodegener 5:31
Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9:1520–1525
Kearney JA (2017) Sodium channel β subunits in epilepsy: location, location, location. Epilepsy Curr 17:52–53
Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM-Y, Woolf CJ (2007) BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9:755–764
Kim J, Yoon H, Chung DE, Brown JL, Belmonte KC, Kim J (2016) miR-186 is decreased in aged brain and suppresses BACE1 expression. J Neurochem 137:436–445
Lee H, Kim C, Ku J-L, Kim W, Yoon SK, Kuh H-J, Lee J-H, Nam SW, Lee EK (2014) A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells. Mol Cells 37:540–546
Li K-X, Lu Y-M, Xu Z-H, Zhang J, Zhu J-M, Zhang J-M, Cao S-X, Chen X-J, Chen Z, Luo J-H (2012) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1. 1 and acts in epilepsy. Nat Neurosci 15:267–273
Lichtenthaler SF, Dominguez DI, Westmeyer GG, Reiss K, Haass C, Saftig P, De Strooper B, Seed B (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem 278:48713–48719
Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, Penke B, Zilberter Y, Harkany T, Pitkanen A, Tanila H (2009) Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29:3453–3462
Nalivaeva NN, Belyaev ND, Turner AJ (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30:509–514
Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen C-H (2008) Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer’s disease mouse models. J Exp Med 205:2781–2789
Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361:260–263
Sima X, Xu J, Li J, Zhong W, You C (2014) Expression of β-amyloid precursor protein in refractory epilepsy. Mol Med Rep 9:1242–1248
Vassar R (2002) β-Secretase (BACE) as a drug target for Alzheimer’s disease. Adv Drug Deliv Rev 54:1589–1602
Vassar R, Cole S (2007) The basic biology of BACE1: a key therapeutic target for Alzheimer’s disease. Curr Genomics 8:509–530
Funding
The current study has been supported by a grant from the Hamadan University of Medical Sciences (Grant Number 9609286012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The local ethical committee of Hamadan University of Medical Sciences(IR.UMSHA.REC.1396.578)approved the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mazdeh, M., Komaki, A., Omrani, M.D. et al. Expression analysis of beta-secretase 1 (BACE1) and its naturally occurring antisense (BACE1-AS) in blood of epileptic patients. Neurol Sci 39, 1565–1569 (2018). https://doi.org/10.1007/s10072-018-3458-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3458-3